The early-response gene product IEX-1 (also known as IER3) was recently found to interact with the anti-apoptotic Bcl-2 family member, myeloid cell leukemia-1 . In this study we show that this interaction specifically and timely controls the accumulation of Mcl-1 in the nucleus in response to DNA damage. The IEX-1 protein is rapidly induced by c-irradiation, genotoxic agents or replication inhibitors, in a way dependent on ataxia telangiectasia mutated (ATM) activity and is necessary for Mcl-1 nuclear translocation. Conversely, IEX-1 protein proteasomal degradation triggers the return of Mcl-1 to the cytosol. IEX-1 and Mcl-1 are integral components of the DNA damage response. Loss of IEX-1 or Mcl-1 leads to genomic instability and increased sensitivity to genotoxic and replicative stresses. The two proteins cooperate to maintain Chk1 activation and G2 checkpoint arrest. Mcl-1 nuclear translocation may foster checkpoint and improve the tumor resistance to DNA damage-based cancer therapies. Deciphering the pathways involved in IEX-1 degradation should lead to the discovery of new therapeutic targets to increase sensitivity of tumor cells to chemotherapy. Cells respond to DNA damage by activating a protein network that recognizes the damaged DNA, triggering cell cycle checkpoints, repair of the damaged DNA and/or cell death. The DNA damage response (DDR) is regulated by two primary signaling pathways activated downstream of the effector kinases, ataxia-telangiectasia mutated (ATM) and ATM-and Rad3-related (ATR), which are mutated in ataxia-telangiectasia and Seckel syndrome, respectively. ATM is activated in response to agents inducing DNA double-strand breaks (DSBs), whereas ATR responds to a broad spectrum of genotoxic stresses. In the presence of DSBs, the Mre11/Rad50/Nbs1 complex accumulates at DNAdamage sites, forming subnuclear foci. Recruitment of ATM to this complex fosters its activation, leading to phosphorylation of numerous substrates, including the histone H2AX that serves as a scaffold for the recruitment of DNA repair and checkpoint signaling proteins. ATM triggers the processing of DSBs into extended regions of single-stranded DNA. ATR is then recruited and activated to RPA-coated ssDNA. ATM and ATR phosphorylate the checkpoint kinases Chk1 and Chk2, respectively, which will give cell the time to repair the damaged DNA by arresting their cycle at the G1-S or G2-M transitions and within the S phase.
1
In the face of irreparable damage the cell may activate its apoptotic machinery. On the contrary, in response to low levels of damage and during the checkpoint arrests, apoptosis needs to be suppressed to allow repair and avoid unnecessary cell destruction. The correct balance between cell cycle arrest and apoptosis is crucial to ensure genomic stability. This suggests a high and complex interplay between proteins controlling the DDR and the apoptotic pathways. Evolutionary conserved Bcl-2 family members are central regulators of apoptosis. Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic member of this family. Models of Mcl-1 knockout mice have shown its requirement for embryonic development and differentiation of various hematopoietic lineages. [2] [3] [4] Mcl-1 is regulated at transcriptional, post-transcriptional and post-translational levels. 5, 6 Its anti-apoptotic function is regulated by interaction with other Bcl-2 family members. 7 Outside of this family, Mcl-1 interacts with proteins regulating apoptosis or cell proliferation, including fortilin, cdk1 and PCNA. [8] [9] [10] Recent studies have identified immediate earlyresponse gene X-1 (IEX-1, also known as IER3) as a new partner of Mcl-1.
11,12 IEX-1 is an early-response gene product that is rapidly induced by growth factors, ionizing radiations and viral infections. Conflicting data have been reported concerning its role in survival: IEX-1 was found to not only increase apoptosis in response to TNF-a, 11, [13] [14] [15] but also to contribute to growth factor-mediated survival 15, 16 and to prevent activation-induced T-cell death. 17, 18 Other functions have been attributed to IEX-1 such as regulation of ERK, Akt and NF-kB signaling pathways. 14, 16, 19 Unlike a previous report, 12 we found that although IEX-1 and Mcl-1 inhibit staurosporin-induced apoptosis, this function is independent of their interaction. A recent study reported that Mcl-1 translocates to the nucleus after treatment with etoposide. 20 In this study we show that Mcl-1 nuclear translocation is a general response to genotoxic stress and that it is strictly and timely controlled by IEX-1. IEX-1 expression is rapidly induced by DNA-damaging agents in an ATM-dependent manner and is necessary for Mcl-1 nuclear translocation. Conversely, IEX-1 protein degradation triggers Mcl-1 return to the cytosol. IEX-1 and Mcl-1 are integral components of the DDR pathway. They cooperate to maintain Chk1 activation, and regulate proper G2 checkpoint arrest and repair of DNA lesions and cell survival after treatments with various DNA-damaging agents. Endogenous IEX-1 and Mcl-1 colocalized in the nucleus and could be co-immunoprecipitated from the nuclear fraction of HeLa cells after HU or IR treatments (Figures 1c and e) . IF analysis in cells subjected to detergent extraction before fixation showed that although the global intensity of the signal was greatly decreased under these conditions, most of the IR-treated cells stained positively for nuclear Mcl-1 and IEX-1 (Figure 1f ). In contrast, the Mcl-1 signal was entirely lost in non-treated cells. This further supports Mcl-1 delocalization upon IR and indicates that IEX-1 and Mcl-1 associate, at least partially, with the chromatin fraction after DNA damage.
HeLa cells expressing IEX-1 short hairpin RNAs (shRNAs) 23 showed a great decrease in both IEX-1 induction and Mcl-1 nuclear accumulation upon HU or IR treatment (Figures 2a  and b) . Fractionation experiments showed that IR increased Mcl-1 levels in the nuclear fraction of cells expressing scramble but not IEX-1 shRNAs (Figure 2c ). Moreover, although in IEX-1 þ / þ hematopoietic progenitors Mcl-1 had entirely moved from the cytoplasm to the nucleus 3 h after IR, its localization remained unchanged in IEX-1 À/À cells (Figure 2d ). Expression of IEX-1 in IEX-1 À/À mouse embryonic fibroblasts (MEFs) restored IR-mediated Mcl-1 nuclear staining (Supplementary Figure S2) . Thus, IEX-1 induction is a prerequisite for IRinduced Mcl-1 nuclear translocation.
ATM activity is required for IEX-1 expression and to maintain Mcl-1 in the nucleus. Both IR-or HU-mediated IEX-1 expression and Mcl-1 nuclear accumulation were abolished in ATM-deficient GM3189 lymphoblastoid cells and upon treatment of HeLa cells with the ATM inhibitors caffeine and KU-55933 (Figures 3a and b) , showing that these events require ATM activity.
IEX-1 is a short half-life protein, sensitive to degradation by the proteasome. In cells treated overnight with HU and then released in HU-free medium, IEX-1 staining was strong at 5 h, started to fade at 9 h and disappeared at 16 h (Figure 3c ). Mcl-1 localized to the nucleus as long as IEX-1 was present and returned to the cytosol when IEX-1 vanished. Addition of the proteasome inhibitor, N-acetyl-Leu-Leu-NorLeu-al (LLnL), at 5 h prevented IEX-1 disappearance and Mcl-1 nuclear exit. In the absence of HU, treatment with LLnL alone for 4 h did not induce IEX-1. In agreement with previous reports, 5, 6 Mcl-1 expression increased slightly under these conditions but it remained mostly located in the cytoplasm. No apoptosis could be detected up to 16 h, showing that neither the nuclear localization of Mcl-1 nor its relocalization to the cytosol is linked to cell death. Thus, IEX-1 is necessary to both bring and maintain Mcl-1 into the nucleus.
To determine whether ATM activity is required to maintain IEX-1 expression once induced, the cells were synchronized, arrested in G2 by IR and then treated with caffeine or KU-55933. 24 Inhibition of ATM activity accelerated IEX-1 degradation and triggered Mcl-1 nuclear exit (Figure 3d Mcl-1 deficiency leads to impaired Chk1 phosphorylation and G2/M arrest. To get insights into the mechanisms by which Mcl-1 influences the DDR, we examined whether its expression affected DNA damage signaling. ATM phosphorylation was not decreased but was rather more pronounced in shMcl-1-expressing HeLa cells (Figure 5a ). The loss of Mcl-1 led to a decreased IR-induced Chk1 phosphorylation on serines 296, 345 and 317, the three sites targeted by ATR (Figures 5a and b ). This effect was particularly striking at longer time points, suggesting that Mcl-1 is not required to activate Chk1 but to maintain its activity. No decrease in the phosphorylation of the other ATM/ATR substrates, Chk2, RPA32, Rad17, SMC1 and NBS1, could be observed. The prolonged phosphorylation of H2AX confirmed the sustained presence of g-H2AX foci in Mcl-1-deficient cells. These data suggest that Mcl-1 contributes to DDR by maintaining selectively Chk1 activation.
Chk1 is required for intra-S and G2/M checkpoint activation. To analyze both phases of the cell cycle, the cells were doubly labeled with BrdU and propidium iodide (PI). Inhibition of Mcl-1 expression had no effect on the unperturbed cell cycle (Figure 5c ). IR induced accumulation of control cells in the S and G2 phases of the cell cycle. Mcl-1 downregulation had no effect on the S-phase progression or on the accumulation in G2 until 6 h after IR. However, at 24 h after IR, although control cells were still blocked in G2, shMcl-1-expressing cells had already started to re-enter in G1. A similar shorter G2 arrest was observed in Mcl-1-deficient MEFs (Supplementary Figure S3-c) . Thus, Mcl-1 is indispensable to maintain Chk1 phosphorylation and the G2 checkpoint, allowing correct DNA repair in response to DNA damage. IEX-1-deficient mice also showed genomic instability. At 1 month after whole-body irradiation, metaphase spreads of cells isolated from IEX-1 À/À bone marrows and spleens showed a significant increase in chromosomal aberrations when compared with controls ( Figure 8d) . Thus, the absence of IEX-1 leads to sustained DNA lesions in hematopoietic cells. However, no difference in survival between WT and IEX-1 À/À mice was observed at that time, suggesting that compensatory mechanisms would limit the effect of this defect on irradiated organisms.
IEX-1-and

Discussion
Cell cycle arrest, survival and DNA repair are coordinately controlled in the face of DNA damage. Recent data have revealed the existence of unexpected direct interactions between checkpoint/repair components and members of the Bcl-2 family or other regulators of the apoptotic pathway. For example, Bid and APAF translocate to the nucleus and affect S-phase arrest after DNA damage, [25] [26] [27] and Bax and Bcl-2 negatively regulate homologous recombination. 28 In this study we show that Mcl-1 is an integral component of the DDR, in multiple types of primary and transformed cells, and in response to various stresses such as IR, genotoxic agents or replication inhibitors. Cells lacking Mcl-1 show altered G2 checkpoint, leading to extended DNA damage and inefficient DNA repair. These defects translate into increased genomic instability and sensitivity in response to DNA damage.
DNA damage triggers a striking accumulation of Mcl-1 in the nucleus and its association with the chromatin. The signal regulating Bid function in DNA damage is provided by ATM phosphorylation. 25, 27 The Mcl-1 protein sequence does not present ATM/ATR phosphorylation sites. We show that Mcl-1 nuclear accumulation and function upon DNA damage occurs in an ATM-dependent manner through a new mechanism involving its association with IEX- To avoid repeated stripping, the same samples were loaded several times on 6-15% acrylamide gels. All the results shown come from unique blots and exposures. Images were cutoff (dotted line) when the samples were not loaded side by side. Quantifications are expressed relative to the levels before IR, after normalization on actin (a) or ERK (b) levels. (c) The cells were incubated for 30 min with BrdU and fixed. After staining with antibodies to BrdU and with PI, the cells were analyzed using flow cytometry. Representative dot plots and mean ± S.E.M. from three independent experiments are shown. *Po0.05
Mcl-1 in the nucleus after DNA damage, allowing maintenance of the G2 arrest and its subsequent switch-off, authorizing the re-entry into the cell cycle.
Previous reports have shown that DNA damage can trigger a rapid decrease in Mcl-1 protein and/or mRNA levels, whereas others have reported the opposite results. 5, 20, 29 These discrepancies may be linked to the types of detergent used to prepare the lysates, as we show that Mcl-1 partially associates with chromatin after DNA damage and/or with the doses of DNA-damaging agents. We did not observe major change in Mcl-1 levels, upon DNA damage, overexpression or downregulation of IEX-1, indicating that IEX-1 alters only Mcl-1 subcellular localization. IEX-1, as Mcl-1, associates with mitochondria and endoplasmic reticulum membranes. 15, 16 IEX-1/Mcl-1 interaction requires their transmembrane domains. Thus, IEX-1 could bind to Mcl-1 in the mitochondrial membrane and then transport it to the nucleus. Supporting this possibility, IEX-1-DNLS was unable to induce Mcl-1 nuclear accumulation and the two proteins co-precipitated from both nuclear and cytosolic fractions. On the other hand, Mcl-1 is present at low levels in the nucleus in the absence of genotoxic stress. [8] [9] [10] Thus, although IEX-1 appears as a major mechanism controlling Mcl-1 nuclear accumulation upon DNA damage, Mcl-1 may transit to the nucleus independently of IEX-1 during the normal cell cycle. This result fits with previous reports showing that overexpression of Mcl-1 inhibits cell cycle progression in the absence of DNA damage. The slow decrease in the comet tail moments in IEX-1-or in Mcl-1-depleted cells after irradiation suggests that these cells accumulate DSBs because of defects in DNA repair. However, their cell cycle arrest was not longer. In fact the opposite is observed. This suggests that IEX-1/Mcl-1 complexes have a major role in checkpoint signaling, at the level or downstream of the activation of the checkpoint kinases. Indeed, Chk1 activation was selectively impaired in the absence of IEX-1 or Mcl-1. This defect can explain why these cells accumulate DSBs; 30 however, how IEX-1 and Mcl-1 cooperate to maintain Chk1 activation is unknown. After IR, several proteins required for the DDR accumulate to chromatin in discrete foci, which are needed for activation of Chk1/Chk2.
1 Although Mcl-1 and IEX-1 partially associate with chromatin, they do not seem to participate to the recruitment of DDR proteins to foci. Indeed, soon after IR, g-H2AX was normally enriched in foci in Mcl-1 or IEX-1-deficient cells. This is consistent with the fact that IEX-1 expression and Mcl-1 nuclear accumulation could be detected only approximately 30 min after IR. Neither the phosphorylation of ATM and its substrates (NBS1, SMC1 and Chk2) nor that of the ATR substrates (RPA and Rad17) required for Chk1 activation 30 was compromised in the absence of Mcl-1, suggesting that IEX-1/Mcl-1 complexes affect signaling downstream of ATM/ATR activation. Jamil et al. 20 have reported that etoposide induces a truncated form of Mcl-1 that associates with Chk1, but we were unable to reproduce these results. This might be because of the different antibodies or lysates conditions used. Claspin binds to Chk1 and ATR and is essential for Chk1 phosphorylation. 31 However, we could not precipitate Mcl-1 or IEX-1 with claspin. Claspin and Chk1 levels were not decreased in Mcl-1-deficient cells, showing that their degradation was not affected. [32] [33] [34] On the other hand, IEX-1 mutants, which were impaired in their ability to inhibit PP2A, 23 could restore the DDR of IEX-1
MEFs (data not shown), suggesting that IEX-1/Mcl-1 do not maintain Chk1 activity by inhibiting its dephosphorylation by these phosphatases. 35 In contrast with the apoptosis ensuing Mcl-1 mitochondrial degradation, 5 the delocalization of Mcl-1 to the nucleus upon DNA damage triggers DNA repair and checkpoint survival signals. IEX-1 depletion increases cell radiosensitivity while leaving intact the Mcl-1-mitochondrial pool. Thus, Mcl-1 function in the DDR requires its nuclear localization and is separately controlled from its activity at the mitochondria. Mcl-1 is overexpressed in many tumors and it is often responsible for the resistance to treatment with the BH3-mimetic ABT-737. 36 Cancer therapies involving DNA-damaging agents have the potential to induce IEX-1 expression and Mcl-1 nuclear localization, in which they may act together to foster checkpoint and improve the tumor resistance to DNA damage. Deciphering the pathways involved in IEX-1 degradation should lead to the discovery of new therapeutic targets to increase tumor cells sensitivity to chemotherapy. Aldrich (Saint Louis, MO, USA). Ku-55933 was from Calbiochem (Darmstadt, Germany). The antibodies used were as follows: rabbit serum anti-IEX-1 was described previously; 16 anti-phospho antibodies to Chk1 (Ser345, Ser317 and Ser296), Chk2, ATM, NBS1, Rad17 and rabbit polyclonal anti-g-H2AX (Cell Signaling Technology, Inc., Danvers, MA, USA); anti-pSer10-Histone H3, mouse monoclonal anti-gH2AX and anti-GFP (Millipore, Billerica, MA, USA); anti-pRPA32 and anti-pSMC1 (Bethyl Labs, Montgomery, TX, USA); anti-Mcl-1 (S19), anti-ERK1 (K23), rabbit anti-Chk1 (Fl-476) and goat anti-IEX-1 (C20) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA); anti-HA (3F10 and 12CA5) and anti-Myc (9E10) (Roche Applied Science, Meylan, France); anti-RAD51 (Calbiochem); anti-actin (C40), anti-Flag (M2) and monoclonal anti-Chk1 (DCS-310) (Sigma Aldrich). Fluorochrome-conjugated antibodies, anti-rabbit AlexaFluor 594 and 647; anti-mouse AlexaFluor 405 (Invitrogen, Carlsbad, CA, USA) and FITC anti-goat; FITC anti-mouse and Rhodamine anti-goat (Jackson Immunoresearch, West Grove, PA, USA).
Cells and mice. IEX-1
À/À and WT littermates mice on the mixed 129/Sv Â C57BL/6 background 37 were imported from the Mayo Clinic (Rochester, MN, USA) and housed in a specific pathogen-free environment. The experiments were conducted following standard ethical guidelines. Primary MEFs were obtained from IEX-1 À/À and IEX-1 þ / þ embryos at day 12 p.c. and resuspended in DMEM supplemented with 10% fetal calf serum (FCS), 1% 
